The Dow plunged more than 100 points, the market corrected after a strong jump yesterday | RYT9

The Dow fell more than 100 points today as a correction. After a huge spike yesterday

As of 10.37 p.m. Thai time, the Dow Jones Industrial Average stood at 31,427.76, negative 107.75 points, or 0.34%.

Shares of Zoom Video Communications Inc, Target and Kohl’s Corp all jumped today. Respond to higher-than-expected earnings

The Dow jumped more than 600 points last night. It hit the highest record in a single day since Nov.9, 2020, after the US approved a vaccine against COVID-19. The markets were also positive from the release of strong economic figures, a weakening US bond yields and a weakening of US Treasury yields. Including the US House of Representatives to approve the economic stimulus measures.

The US House of Representatives voted in favor of the $ 1.9 trillion stimulus package over the weekend. And it is now in the Senate hearing. Before sending it to President Joe Biden signed the endorsement into law.

U.S. House Speaker Nancy Pelosi expects the approval of the stimulus process to be completed by March 15, the day the unemployment measures affected by COVID-19 expire.

One senior US government official said: President Joe Biden will make an announcement today for Merck. Which is a major drug manufacturer Acquires Johnson & Johnson (J&J) in the production of the COVID-19 vaccine.

The announcement was made. Amid efforts by the US government to increase production of the COVID-19 vaccine. Of the Johnson & Johnson Company

The government earlier said that 3.9 million doses of Johnson & Johnson vaccine would be delivered this week. But there are concerns that vaccine production will be below target in the coming weeks. While the government wants to distribute more than 16 million doses of the vaccine by the end of this month.

Under an agreement with the US government Merck will use two US plants for the Johnson & Johnson vaccine production.

The US government has rushed to find a facility to increase Johnson & Johnson’s vaccine production after it was found that the vaccine was delayed. And finally, the government reached an agreement with Merck to help produce Johnson & Johnson’s COVID-19 vaccine, while Merck abandoned its own vaccine development program. This is because clinical trials have shown that the company’s vaccine is ineffective against COVID-19.

Investors had their eyes on the Federal Reserve’s monetary policy meeting on March 16-17, after Fed Chairman Jerome Powell said in a half-year statement to Congress last week: The Fed will continue its monetary easing policy. While signaling to freeze interest rates near 0% for the next 3 years


Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.